000			na a22 7a 4500
999			_c17965 _d17965
003			PC17965
005			20250526100240.0
008			250507b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aspa, eng
100			_9889 _aRivera Díaz, Raquel _eDermatología Médico-Quirúrgica y Venereología
245	0	0	_aEnfermedad renal y psoriasis. ¿Una nueva comorbilidad?. _h[artículo]
260			_bActas dermo-sifiliográficas, _c2016
300			_a107(10):823-29.
500			_aFormato Vancouver: González Parra E, Daudén E, Carrascosa JM, Olveira A, Botella R, Bonanad C et al; en representación del Grupo de Trabajo en Inflamación Sistémica en Psoriasis. Kidney Disease and Psoriasis. A New Comorbidity? Actas Dermosifiliogr. 2016 Dec;107(10):823-29.
501			_aPMID: 27497509
504			_aContiene 70 referencias
520			_aPsoriasis is a chronic inflammatory disease that has been associated with cardiovascular and metabolic comorbidities, particularly in young patients and patients with more severe forms of the disease. Recent studies have also linked psoriasis to kidney disease, and this would seem only logical, as the kidney is both a target of classic cardiovascular risk factors and susceptible to the toxic effects of some of the traditional drugs used to control psoriasis. In this article, we would like to draw readers' attention to this recently described comorbidity and stress the importance of early detection, as once chronic kidney disease develops, it cannot be reversed. When evaluating patients with psoriasis, particularly when they are candidates for systemic therapy, we believe it is important to order laboratory tests including glomerular filtration rate and a simple urine test to screen for albuminuria (albumin/creatinine ratio).
710			_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17965.pdf _ySolicitar documento
942			_2ddc _cART _n0